Herbalife Shakes Off Market Dive After Investor Scare
This article was originally published in The Tan Sheet
Executive Summary
David Einhorn’s questions during Herbalife’s Q1 earnings call sowed market doubt about the firm, whose stock dropped about 20% May 1. But analysts called the panic behind the sell-off “unwarranted” given the firm’s strong Q1 performance and sound fundamentals.
You may also be interested in...
Herbalife Rides Daily Consumption To Q2 Earnings Jump, Revised Guidance
Herbalife's daily consumption model is bearing substantial fruit across many of its 73 markets, driving record sales and prompting a significant earnings guidance hike
Herbalife Touts Vertical Integration As Key To Traceability, Cost Control
Herbalife looks to improve its bottom line by bringing its manufacturing and sourcing functions in-house, according to Chief Financial Officer John DeSimone
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.